Celebrating 25 years Est 1999-2024
*Across 3 years $2158.56 only $1079.28
Jarden analyst Steven Wheen maintained a Buy rating on CSL (CMXHF - Research Report) on November 25 and set a price target of A$322.52. The...
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Arcus Biosciences (RCUS – Research Report...
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Arcus Biosciences (RCUS – Research Report) and CSL...
E ratio of 40.88.https://www.tipranks.com/news/blurbs/csl-cmxhf-gets-a-buy-from-morgan-stanley-2?utm_source=advfn.com&utm_medium=referral
Macquarie analyst David Bailey maintained a Buy rating on CSL (CMXHF - Research Report) today and set a price target of A$343.00. The company's...
Morgan Stanley analyst Sean Laaman maintained a Buy rating on CSL (CMXHF - Research Report) today and set a price target of A$327.00. The...
Citigroup analyst Mathieu Chevrier maintained a Buy rating on CSL (CMXHF - Research Report) today and set a price target of A$340.00. The...
Analysts have been eager to weigh in on the Healthcare sector with new ratings on CSL (CMXHF – Research Report) and Ayala Pharmaceuticals (AYLA –...
Jarden analyst Steven Wheen maintained a Buy rating on CSL (CMXHF - Research Report) on October 19 and set a price target of A$312.83. The...
Wilsons analyst Shane Storey maintained a Buy rating on CSL (CMXHF - Research Report) on October 19 and set a price target of A$342.55. The...
Goldman Sachs analyst Chris Cooper maintained a Hold rating on CSL (CMXHF - Research Report) on October 17 and set a price target of A$291.00. The...
In a report released on September 16, Shane Storey from Wilsons maintained a Buy rating on CSL (CMXHF - Research Report), with a price target of...
Analysts have been eager to weigh in on the Healthcare sector with new ratings on CSL (CMXHF – Research Report) and Cochlear Limited (CHEOF –...
Goldman Sachs analyst Chris Cooper maintained a Hold rating on CSL (CMXHF - Research Report) on August 18 and set a price target of A$291.00. The...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.